A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
for Advanced Solid Tumor
13 locations incl. Jacksonville
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05932862·Phase 1·Recruiting·Listed Jul 2023
Exelixis Clinical
Clinical research site in New Brunswick, New Jersey
Part of Exelixis Clinical
As of July 2026, 2 paid clinical trials are recruiting at Exelixis Clinical in New Brunswick, New Jersey. Active studies at this site cover conditions such as Advanced Solid Tumor and Solid Tumors. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Exelixis Clinical (2)
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
for Solid Tumors
9 locations incl. Rogers
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT07123103·Phase 1·Recruiting·Listed Aug 2025
More research sites in New Brunswick
- Rutgers Cancer Institute of New Jersey (111 trials)
- Rutgers Cancer Institute (33 trials)
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital (24 trials)
- Saint Peter's University Hospital (22 trials)
- Rutgers Robert Wood Johnson Medical School (18 trials)
- Robert Wood Johnson University Hospital (17 trials)
- Rutgers University (11 trials)
- Robert Wood Johnson Medical School (10 trials)
- RWJBarnabas Health - Robert Wood Johnson University Hospital (6 trials)
- Rutgers (5 trials)
Explore more
Paid clinical trials in New Brunswick, NJ · New Jersey clinical trials